These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19431074)

  • 1. siRNA for inflammatory diseases.
    Ponnappa BC
    Curr Opin Investig Drugs; 2009 May; 10(5):418-24. PubMed ID: 19431074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA delivery systems for cancer treatment.
    Oh YK; Park TG
    Adv Drug Deliv Rev; 2009 Aug; 61(10):850-62. PubMed ID: 19422869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
    Li SD; Huang L
    Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicinal delivery approaches for therapeutic siRNA.
    Keller M
    Int J Pharm; 2009 Sep; 379(2):210-1. PubMed ID: 19716034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA.
    Liu B
    Brief Funct Genomic Proteomic; 2007 Jun; 6(2):112-9. PubMed ID: 17670766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in synthetic siRNA delivery.
    Manjunath N; Dykxhoorn DM
    Discov Med; 2010 May; 9(48):418-30. PubMed ID: 20515610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. siRNA-mediated antitumorigenesis for drug target validation and therapeutics.
    Lu PY; Xie FY; Woodle MC
    Curr Opin Mol Ther; 2003 Jun; 5(3):225-34. PubMed ID: 12870431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhalable siRNA: potential as a therapeutic agent in the lungs.
    Durcan N; Murphy C; Cryan SA
    Mol Pharm; 2008; 5(4):559-66. PubMed ID: 18491918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. siRNAs: their potential as therapeutic agents--Part II. Methods of delivery.
    Singh SK; Hajeri PB
    Drug Discov Today; 2009 Sep; 14(17-18):859-65. PubMed ID: 19540929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery of siRNA therapeutics: potentials and limits of nanosystems.
    Reischl D; Zimmer A
    Nanomedicine; 2009 Mar; 5(1):8-20. PubMed ID: 18640078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonviral siRNA delivery for gene silencing in neurodegenerative diseases.
    Prakash S; Malhotra M; Rengaswamy V
    Methods Mol Biol; 2010; 623():211-29. PubMed ID: 20217554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short interfering RNA (siRNA): tool or therapeutic?
    Cejka D; Losert D; Wacheck V
    Clin Sci (Lond); 2006 Jan; 110(1):47-58. PubMed ID: 16336204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged gene silencing in hepatoma cells and primary hepatocytes after small interfering RNA delivery with biodegradable poly(beta-amino esters).
    Vandenbroucke RE; De Geest BG; Bonné S; Vinken M; Van Haecke T; Heimberg H; Wagner E; Rogiers V; De Smedt SC; Demeester J; Sanders NN
    J Gene Med; 2008 Jul; 10(7):783-94. PubMed ID: 18470950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. siRNA delivery using peptide transduction domains.
    Eguchi A; Dowdy SF
    Trends Pharmacol Sci; 2009 Jul; 30(7):341-5. PubMed ID: 19545914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
    Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs.
    de Jonge J; Holtrop M; Wilschut J; Huckriede A
    Gene Ther; 2006 Mar; 13(5):400-11. PubMed ID: 16267567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small interfering RNA for experimental cancer therapy.
    Tong AW; Zhang YA; Nemunaitis J
    Curr Opin Mol Ther; 2005 Apr; 7(2):114-24. PubMed ID: 15844618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
    Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
    Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.